Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jupiter Neurosciences (JUNS) Share-based Compensation (2024 - 2025)

Jupiter Neurosciences (JUNS) has disclosed Share-based Compensation for 2 consecutive years, with $389707.0 as the latest value for Q4 2025.

  • Quarterly Share-based Compensation fell 56.4% to $389707.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.5 million through Dec 2025, up 72.99% year-over-year, with the annual reading at $1.5 million for FY2025, 72.99% up from the prior year.
  • Share-based Compensation for Q4 2025 was $389707.0 at Jupiter Neurosciences, roughly flat from $389707.0 in the prior quarter.
  • The five-year high for Share-based Compensation was $893781.0 in Q4 2024, with the low at -$632300.0 in Q3 2024.